Nocardiosis ‘great imitator’: unusual disease with usual presentations at unusual site
DOI:
https://doi.org/10.18203/issn.2455-4510.IntJResOrthop20234067Keywords:
Antibiotic therapy, Cutaneous nocardiosis, Dequervain tenosynovitis, Immunocompetent hosts, Nocardia farcinicaAbstract
Nocardia, an aerobic actinomycete, typically affects immunosuppressed individuals, commonly manifesting in the lungs. Cutaneous infections, particularly by N. pseudobrasiliensis, can occur, presenting as lympho-cutaneous, superficial, or mycetoma subtypes. Nocardia farcinica, resistant to third-generation cephalosporins, is particularly virulent. A 50-year-old female with type 2 diabetes presented with painful nodules, bullae, and recurrent discharge over the left wrist, mimicking cellulitis. Culture-sensitivity revealed Nocardia farcinica. Treatment involved debridement, De quervain release and prolonged Linezolid therapy for a complete cure. Cutaneous Nocardiosis can mimic cellulitis, posing diagnostic challenges due to slow growth and microbiological detection. N. farcinica demonstrated resistance to conventional antibiotics. This case emphasizes the importance of considering Nocardia infections in diverse clinical presentations, highlighting the need for a comprehensive diagnostic approach, especially in immunocompromised individuals.
References
Mehta HH, Shamoo Y. Pathogenic Nocardia: A diverse genus of emerging pathogens or just poorly recognized? PLoS Pathog. 2020;16(3):e1008280.
Thieman T, Swali R, Clarey D, Evans T, Lee E, Georgesen C. A 72-Year-Old Woman With Hemorrhagic Bullae Over the Dorsal Hand: Answer. Am J Dermatopathol. 2022;44(6):463.
McNeil MM, Brown JM. The medically important aerobic actinomycetes: epidemiology and microbiology. Clin Microbiol Rev. 1994;7(3):357-417.
Baio PV, Ramos JN, Santos LS, Soriano MF, Ladeira EM, Souza MC, et al. Molecular identification of nocardia isolates from clinical samples and an overview of human nocardiosis in Brazil. PLoS Negl Trop Dis. 2013;7(12):e2573.
Beaman BL, Beaman L. Nocardia species: host-parasite relationships. Clin Microbiol Rev. 1994;7(2):213-64.
Beaman BL. Induction of L-phase variants of Nocardia caviae within intact murine lungs. Infect Immun. 1980;29(1):244-51.
Mehta H, Weng J, Prater A, Elworth RAL, Han X, Shamoo Y. Pathogenic Nocardia cyriacigeorgica and Nocardia nova Evolve To Resist Trimethoprim-Sulfamethoxazole by both Expected and Unexpected Pathways. Antimicrob Agents Chemother. 2018;62(7):e00364-18.
Zhao P, Zhang X, Du P, Li G, Li L, Li Z. Susceptibility profiles of Nocardia spp. to antimicrobial and antituberculotic agents detected by a microplate Alamar Blue assay. Sci Rep. 2017;(7):43660.
Conville PS, Brown-Elliott BA, Smith T, Zelazny M. The Complexities of Nocardia Taxonomy and Identification. J Clin Microbiol. 2018;56(1):e01419-17.
Wang HL, Seo YH, LaSala PR, Tarrand JJ, Han XY. Nocardiosis in 132 patients with cancer: microbiological and clinical analyses. Am J Clin Pathol. 2014;142(4):513-23.
Coussement J, Lebeaux D, Delden C, Guillot H, Freund R, Marbus S, et al. Nocardia Infection in Solid Organ Transplant Recipients: A Multicenter European Case-control Study. Clin Infect Dis. 2016;63(3):338-45.
Elliott BA, Brown JM, Conville PS, Wallace RJ Jr. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev. 2006;19(2):259-82.
Wilson JW. Nocardiosis: updates and clinical overview. Mayo Clin Proc. 2012;87(4):403-7.
